Trial intelligence / Profile preview

Hyperfractionated Pre-Op Chemo-Radiation for Rectal Cancer

NCT00021398Phase 2Completed

Sponsor
Fox Chase Cancer Center
Start
Jul 1996
Primary completion
Jul 2001
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of fluorouracil in rectal cancer, sponsored by Fox Chase Cancer Center. Started Jul 1996; status: completed.

02

Drugs

fluorouracil
03

Conditions

rectal cancer

Beyond the preview

Go deeper on NCT00021398.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00021398.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call